The presentation will be made available on the Company website in the presentations section on the day of the event:
www.bergenbio.com/investors/presentations/
-End-
Contacts
ir@bergenbio.com
rune.skeie@bergenbio.com
Investor Relations / Media Relations
jl@lillebyfrisch.no
About
Forward looking statements
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties, and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
https://news.cision.com/bergenbio-asa/r/bergenbio-to-present-at-dnb-nordic-healthcare-conference,c3891385
(c) 2023 Cision. All rights reserved., source